Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance.
about
PharmGKB summary: cyclosporine and tacrolimus pathwaysReceptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.Genetic basis of psoriasis vulgaris and its pharmacogenetic potential.From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.Cytochrome P450 3A polymorphisms and immunosuppressive drugs.Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipientsPharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation.Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks.Pharmacogenetics in kidney transplantation: recent updates and potential clinical applications.Personalized treatment in heart transplantation.Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis.The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy.
P2860
Q33989902-CE4CCD57-AEAA-4DC8-8D83-2E1338305A70Q34604457-C2E1C458-A680-4C87-83D2-CC10CF560BBCQ35116099-E916BA93-DBC2-440E-8FFE-641478FE3ED7Q35666588-E5748C58-D88E-47AC-A2A4-A23911CA0FE7Q36050572-E726D1D9-4FC9-4FD2-B970-75F9A0982219Q36120833-058036C7-02BA-4B37-8658-807619A1290EQ36186945-A267D1D1-9014-4878-B57D-57197CEE8751Q36326210-C0263432-452A-46A8-848A-94E2E792CA5AQ36783322-167C4EF2-CAF4-4A20-A495-654530297EE4Q36916904-DDD588D3-675B-4B9B-8987-D049DBD89437Q37074093-D57E0880-58F8-4216-A0D8-983055F97734Q37478703-1DD487D0-042E-4C79-8934-77812C69566DQ37678060-B49698FC-93E9-4508-B2EC-DAE9FD744A76Q38063426-B55D64E1-CB78-4FEE-946C-B313A2082A1AQ38925305-A17F2381-0F7A-44B9-AC85-B3A1F7D22D00Q42173355-74219CB2-D0D2-462F-BB21-568B0847913AQ44899003-69467D53-387E-4D77-A1D8-D142D0EA42EAQ45262234-97174316-B0C3-4462-A9D4-B373E86AB642
P2860
Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@ast
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@en
type
label
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@ast
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@en
prefLabel
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@ast
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@en
P2093
P356
P1476
Frequency of cytochrome P450 3 ...... on with cyclosporin clearance.
@en
P2093
P2888
P304
P356
10.1007/S002280000166
P577
2000-08-01T00:00:00Z
P6179
1040962032